Levodopa
Levodopa is an amino acid precursor of dopamine, primarily used in the treatment of Parkinson’s disease. It crosses the blood-brain barrier and is converted to dopamine in the central nervous system to compensate for depleted dopamine supply.
• Treatment of Parkinson’s disease and related movement disorders by replenishing dopamine levels in the brain.
• Precursor for dopamine synthesis in the central nervous system when combined with peripheral decarboxylase inhibitors.
• Used in pharmaceutical formulations for managing neurological conditions and improving motor function.
• Applied in research on neurodegenerative diseases and dopaminergic pathway studies.
• Utilized in combination therapies to enhance bioavailability and therapeutic efficacy.
Product Name: Levodopa
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.